Legg-Calvé-Perthes Disease Does Not Cause Direct Cardiovascular Complications, But Patients Have Increased Long-Term Cardiovascular Risk
Legg-Calvé-Perthes disease (LCPD) itself does not cause acute cardiovascular complications, but patients with LCPD have a significantly elevated risk of developing cardiovascular diseases later in life, with a 70% increased risk compared to the general population.
Understanding the Cardiovascular Association
LCPD is an avascular necrosis of the proximal femoral epiphysis in children, typically occurring between ages 4-10 years 1, 2. The disease does not produce immediate cardiac symptoms or complications during the acute phase. However, a large Swedish registry study of 3,141 LCPD patients followed over 40 years demonstrated a hazard ratio of 1.70 (95% CI: 1.39-2.09) for cardiovascular diseases 3.
Key Risk Patterns by Age
The cardiovascular risk becomes more pronounced with age:
- Patients over 30 years old show a hazard ratio of 2.10 (95% CI: 1.52-2.91) for cardiovascular disease 3
- Hypertensive disease risk is nearly tripled (HR: 2.97,95% CI: 1.87-4.72) 3
- Blood disorders including anemias and coagulation defects show increased risk (HR: 1.41), which rises to 2.70 in patients over 30 years 3
The Vascular Pathophysiology Connection
The association between LCPD and later cardiovascular disease supports the hypothesis that underlying vascular pathology, rather than the orthopedic condition itself, drives both the femoral head necrosis and subsequent cardiovascular risk 3. The disease results from insufficient blood supply to the femoral head, suggesting systemic vascular dysfunction may be present from childhood 3, 4.
Recent perfusion MRI studies demonstrate that revascularization in LCPD involves both the medial femoral circumflex artery and the artery of ligamentum teres, with 50% of hips showing separate medial and lateral perfusion sources 4. This vascular imaging evidence reinforces that LCPD reflects broader vascular compromise.
Clinical Management Implications
During Active LCPD Phase (Childhood)
- No cardiac monitoring or cardiovascular interventions are indicated during acute disease management
- Focus remains on orthopedic containment procedures (femoral varus osteotomy, Salter's innominate osteotomy, or triple pelvic osteotomy) 1
- Treatment aims to prevent femoral head deformity and premature hip osteoarthritis 2
Long-Term Cardiovascular Surveillance (Adulthood)
Patients with a history of LCPD require enhanced cardiovascular risk factor screening starting in early adulthood:
- Blood pressure monitoring for hypertension detection (given the 3-fold increased risk) 3
- Lipid profile assessment for atherosclerotic disease prevention
- Screening for coagulation disorders and anemia, particularly after age 30 (HR: 2.70 for blood diseases) 3
- Standard cardiovascular risk factor modification including smoking cessation, weight management, and exercise as tolerated by hip function
Important Caveats
The provided guidelines on peripheral arterial disease, heart failure, and large vessel vasculitis 5, 6, 7, 6, 8 do not address LCPD specifically, as this is a pediatric orthopedic condition with delayed cardiovascular manifestations rather than a primary vascular disease. The cardiovascular risks emerge decades after the initial orthopedic diagnosis.
The critical clinical takeaway is that LCPD should be recognized as a marker for future cardiovascular disease risk, warranting lifelong cardiovascular surveillance rather than acute cardiac management during the childhood disease phase 3.